Navigation Links
Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
Date:3/25/2009

h and development projects, the efficacy of REOLYSIN as a cancer treatment, the tolerability of REOLYSIN outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting
2. Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
3. Oncolytics Biotech(R) Inc. Collaborators Update Combination REOLYSIN(R) and Docetaxel Trial Results at Replicating Oncolytic Virus Meeting
4. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting
5. Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
6. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America
7. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
8. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
9. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
10. Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
11. Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... MADRID , Nov. 26, 2014 ... presented results from a survey of European physicians ... Meeting on Innovation and Biological Therapies" at the ... The event, hosted by EuropaBio and the Spanish ... Ministry of Health, physicians from Spanish oncology and ...
(Date:11/26/2014)... Whitehouse Laboratories is pleased to announce ... (New Jersey) Chamber of Commerce as a member. ... in the North Jersey area, offers Whitehouse Laboratories ... clients in the pharmaceutical and biotechnology areas that ... enables Whitehouse Laboratories a higher level of visibility ...
(Date:11/26/2014)... 2014 The Pittcon marketing department is ... and exposition mobile app, Pittcon 2015 ... the App Store for iOS and Android devices and ... before, during and after the event. It acts as ... companies, technical sessions, Conferee Networking sessions and short courses. ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 CUREā„¢ ... recognition reception on December 5, 2014, in San Francisco ... The MPN Heroes event will honor clinicians, caregivers, and ... of myeloproliferative neoplasms (MPNs). , Special guest speaker ... his family's cancer journey at the reception. Over ...
Breaking Biology Technology:ASBM Presents European Physicians Survey at Spanish Ministry of Health 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 3Pittcon Releases 2015 Mobile App 2CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4
... important milestone toward the realization of a large-scale quantum computer, ... control of light, were accomplished by a team of scientists ... The study, published in the Feb. 7 issue of the ... University, China, and NEC Corporation, Japan. The experimental effort was ...
... (OTC Bulletin Board: TBIO ) today announced ... deliver the Company,s corporate presentation at Lippert/Heilshorn & Associates ... February 17, 2011 at 11:30 a.m. Eastern time. ... slide presentation at: www.transgenomic.com , or from the ...
... Feb. 15, 2011 Reportlinker.com ... research report is available in ... Frontiers in Carbohydrates Developments: Report ... & Bioplastics – Food & ...
Cached Biology Technology:International team of scientists says it's high 'NOON' for microwave photons 2Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17 2Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17 3Reportlinker Adds Frontiers in Carbohydrates Developments: Report 4; Research, Technologies; Biotechnology, Bioprocessing & Bioplastics - Food & Industrial Raw Material, January 2011 2Reportlinker Adds Frontiers in Carbohydrates Developments: Report 4; Research, Technologies; Biotechnology, Bioprocessing & Bioplastics - Food & Industrial Raw Material, January 2011 3
(Date:11/7/2014)... conjunction with the Glendale and ... the Verdugos has announced the " GLENDALE - ... to keep the Verdugo Regional Crime Lab operational after its ... existence, the Lab has processed more than 400 DNA samples, ... "Because our number one priority is the wellbeing of ...
(Date:11/6/2014)... 2014 - Insilico Medicine, Inc, a Baltimore-based bioinformatics ... related diseases announced a research collaboration with the ... Oncology, Inc (OTC: CSBR). , "There are many ... but Champions Oncology,s TumorGraft technology is unique in ... regimen experimentally generating vast amounts of valuable data. ...
(Date:11/4/2014)... death at the right time might actually help boost ... could help in understanding animal populations, pest control and ... in the journal Trends in Ecology and Evolution ... that the kind of positive population effect an overall ... depends on the size and developmental stage of the ...
Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2When less is more: Death in moderation boosts population density in nature 2
... John England, Professor and Chairman of Neurology at LSU Health ... for the quality and accuracy of evidence analysis and the ... Lou Gehrig,s disease, or amyotropic lateral sclerosis (ALS). The guidelines ... Neurology , the journal of the American Academy of ...
... miss its agreed target to stem biodiversity loss by next ... landmark conference devoted to biodiversity science. The goal ... UN Convention on Biological Diversity in April 2003. Some ... reduction of the current rate of biodiversity loss at the ...
... way embryonic stem cells develop into heart muscle in a ... first step toward growing a living "heart patch" to repair ... experiments using mouse embryonic stem cells, the bioengineers used a ... "patch" made up of heart muscle cells, known as cardiomyocytes. ...
Cached Biology News:LSUHSC's England plays key role in developing new ALS treatment guidelines 2World will miss 2010 target to stem biodiversity loss, experts say 2World will miss 2010 target to stem biodiversity loss, experts say 3World will miss 2010 target to stem biodiversity loss, experts say 4World will miss 2010 target to stem biodiversity loss, experts say 5World will miss 2010 target to stem biodiversity loss, experts say 6New strategy for mending broken hearts? 2
...
Human PDGF, CF...
... The mycobacteria ... other cells to the injection site which ... Complete Freund's Adjuvant is used for the ... for the subsequent boosts. Antigens (preferably in ...
2,4-Dinitrophenyl hapten is conjugated to Keyhole Limpet (KLH) protein through lysine....
Biology Products: